MétaCan
Menu
← Back to cohort

Impact of atorvastatin on serum oestradiol and estrone concentrations in postmenopausal women with chronic coronary artery disease: a randomized trial

2025· article· en· W7128072935 on OpenAlexaff
N F O Faria, J R O Nascimento, K L Kuwabara, C M C Strunz, G R Sampaio, E A F S Torres, L A M Cesar, A Mansur

Bibliographic record

VenueEuropean Heart Journal · 2025
Typearticle
Languageen
FieldMedicine
TopicMenopause: Health Impacts and Treatments
Canadian institutionsWiLAN (Canada)
Fundersnot available
KeywordsEstroneAtorvastatinMenopausePlaceboPostmenopausal womenCoronary artery diseaseRandomized controlled trialEstrogen

Abstract

fetched live from OpenAlex

Abstract Background Atorvastatin is widely used to reduce cardiovascular events in patients with chronic atherosclerotic coronary artery disease (CAD). However, the absolute rates of reduction of these events are lower in women even though they are, on average, older and have a higher burden of cardiovascular risk factors compared to men. This reduced efficacy may be linked to the drug’s influence on serum concentrations of endogenous oestrogens. In postmenopausal women, estrone is the predominant endogenous oestrogen and, although less potent than oestradiol, has demonstrated protective effects against atherosclerosis. Purpose To analyse the impact of atorvastatin on serum oestradiol and estrone concentrations in postmenopausal women with chronic atherosclerotic CAD. Methods A randomized, double-blind, placebo-controlled study lasting 60 days included 38 natural postmenopausal women who were less than 70 years old with chronic CAD. Natural menopause was defined as one year of amenorrhea and CAD in the presence of at least one major coronary artery with more than 50% luminal reduction. The participants were divided into a placebo group and an atorvastatin (80 mg/day) group. Before randomization, they underwent a 40-day washout without lipid-lowering drugs, maintaining their usual dietary pattern. Clinical and laboratory assessments were performed at baseline and after 60 days, including triglycerides, total cholesterol, HDL, LDL, glucose, glycated haemoglobin, C-reactive protein, oestradiol, and estrone. Results The mean age of the postmenopausal women was 61±5.05 years, with 17 (45%) in the atorvastatin group and 21 (55%) in the placebo group. Baseline characteristics were similar between the two groups. The Table below presents the mean ± SD values for body mass index and serum concentrations of total cholesterol, HDL, LDL, glucose, glycated haemoglobin (HbA1c), C-reactive protein (CRP), oestradiol, and estrone in each group. Plasma estrone concentration significantly decreased in the atorvastatin group, from 3.4±1.3 to 2.8±0.8 ng/mL (p=0.010) (Figure). Conclusion Atorvastatin reduced serum estrone concentrations, which may partly explain the lower efficacy of statins in postmenopausal women. Future studies with more participants and longer follow-ups are needed to confirm these findings and clarify the mechanisms involved.Table Figure

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.018

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.002
Bibliometrics0.0000.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.333
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Heart Journal→Same topicMenopause: Health Impacts and Treatments→French-language works237,207→